These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33690860)

  • 1. Utilization Patterns of Skeletal Muscle Relaxants Among Commercially Insured Adults in the United States from 2006 to 2018.
    Li Y; Delcher C; Reisfield GM; Wei YJ; Brown JD; Winterstein AG
    Pain Med; 2021 Oct; 22(10):2153-2161. PubMed ID: 33690860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review.
    Chou R; Peterson K; Helfand M
    J Pain Symptom Manage; 2004 Aug; 28(2):140-75. PubMed ID: 15276195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Risk of Opioid Overdose With Concomitant Use of Prescription Opioids and Skeletal Muscle Relaxants.
    Khan NF; Bykov K; Barnett ML; Glynn RJ; Vine SM; Gagne JJ
    Neurology; 2022 Sep; 99(13):e1432-e1442. PubMed ID: 35835561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relative Efficacy of Seven Skeletal Muscle Relaxants. An Analysis of Data From Randomized Studies.
    Abril L; Zamora C; Cordero M; Williams AR; Friedman BW
    J Emerg Med; 2022 Apr; 62(4):455-461. PubMed ID: 35067395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle relaxants for pain management in rheumatoid arthritis.
    Richards BL; Whittle SL; Buchbinder R
    Cochrane Database Syst Rev; 2012 Jan; 1():CD008922. PubMed ID: 22258993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Risk of Injury with Concurrent Use of Opioids and Skeletal Muscle Relaxants.
    Chen C; Hennessy S; Brensinger CM; Miano TA; Bilker WB; Dublin S; Chung SP; Horn JR; Tiwari A; Leonard CE
    Clin Pharmacol Ther; 2024 Jul; 116(1):117-127. PubMed ID: 38482733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baclofen and the risk of fall and fracture in older adults: A real-world cohort study.
    Hwang YJ; Chang AR; Brotman DJ; Inker LA; Grams ME; Shin JI
    J Am Geriatr Soc; 2024 Jan; 72(1):91-101. PubMed ID: 37933734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Physician Prescribing of Muscle Relaxants in the United States, 2005-2016.
    Soprano SE; Hennessy S; Bilker WB; Leonard CE
    JAMA Netw Open; 2020 Jun; 3(6):e207664. PubMed ID: 32579193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle relaxant use in the United States: data from the Third National Health and Nutrition Examination Survey (NHANES III).
    Dillon C; Paulose-Ram R; Hirsch R; Gu Q
    Spine (Phila Pa 1976); 2004 Apr; 29(8):892-6. PubMed ID: 15082991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone.
    Toth PP; Urtis J
    Clin Ther; 2004 Sep; 26(9):1355-67. PubMed ID: 15530999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tizanidine: Advances in Pharmacology & Therapeutics and Drug Formulations.
    Zhu LL; Wang YH; Zhou Q
    J Pain Res; 2024; 17():1257-1271. PubMed ID: 38529017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Schedule IV controlled substance classification on carisoprodol utilization in the United States: An interrupted time series analysis.
    Li Y; Delcher C; Brown JD; Wei YJ; Reisfield GM; Winterstein AG
    Drug Alcohol Depend; 2019 Sep; 202():172-177. PubMed ID: 31352307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrally acting oral skeletal muscle relaxants.
    Elenbaas JK
    Am J Hosp Pharm; 1980 Oct; 37(10):1313-23. PubMed ID: 6999895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choosing a skeletal muscle relaxant.
    See S; Ginzburg R
    Am Fam Physician; 2008 Aug; 78(3):365-70. PubMed ID: 18711953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription of nonsteroidal anti-inflammatory drugs and muscle relaxants for back pain in the United States.
    Luo X; Pietrobon R; Curtis LH; Hey LA
    Spine (Phila Pa 1976); 2004 Dec; 29(23):E531-7. PubMed ID: 15564901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of In Vitro Metabolism of Opioids by Skeletal Muscle Relaxants.
    Moody DE; Fu Y; Fang WB
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):327-334. PubMed ID: 29504673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for Spine-Related Pain in Older Adults.
    Fu JL; Perloff MD
    Drugs Aging; 2022 Jul; 39(7):523-550. PubMed ID: 35754070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of injury associated with skeletal muscle relaxant use in older adults.
    Spence MM; Shin PJ; Lee EA; Gibbs NE
    Ann Pharmacother; 2013; 47(7-8):993-8. PubMed ID: 23821610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data.
    Owens C; Pugmire B; Salness T; Culbertson V; Force R; Cady P; Steiner J
    Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized, Placebo-Controlled Trial of Ibuprofen Plus Metaxalone, Tizanidine, or Baclofen for Acute Low Back Pain.
    Friedman BW; Irizarry E; Solorzano C; Zias E; Pearlman S; Wollowitz A; Jones MP; Shah PD; Gallagher EJ
    Ann Emerg Med; 2019 Oct; 74(4):512-520. PubMed ID: 30955985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.